Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication (OvaNext®)
Hereditary breast and ovarian cancer (HBOC) syndrome is an autosomal dominant disease primarily associated with mutations in BRCA1 or BRCA2 genes. In addition to BRCA1 and BRCA2, there are some other gene mutation associated with HBOC that may also be used in the evaluation of risk for breast and ovarian cancer. Other less common genes include: TP53, PTEN, CDH1, ATM, CHEK2 or PALB2 and STK11. The main characteristics of the HBOC is increased risk of breast and ovarian cancers. In addition, patients with these mutations have increased risk of other cancers such as pancreatic cancer, fallopian tube cancer, male breast cancer, prostate cancer, and melanoma. Current data indicate the risk of developing breast cancer is around 5-10% and 10-15% for ovarian cancers in patients harboring such mutations.
Genetic testing for BRCA1 and BRCA2 will identify 88-90% of HBOC cases. Expanded multi-gene panel that includes most common gene mutations with HBOC including TP53, PTEN, CDH1, ATM, CHEK2 or PALB2 and STK11 will detect additional cases and may be useful in BRCA1/2 negative patients when there is a suspicion of hereditary cancer susceptibility.
- Screening for hereditary breast and ovarian cancer syndrome
- Screening for hereditary susceptibility to breast and ovarian cancer and cancer risk-reducing management
- As an aid in diagnosis and prognosis of breast and ovarian cancer
- Potential information for preventive and pre-emptive therapy or intervention
Negative for mutation analyzed (No reportable variants were identified)
Whole blood (EDTA).
Stability
- Ambient: 5-7 days
- Refrigerated: 7-14 days
- Int J Clin Oncol. 2017 Nov 28. 1208-9. [PMID: 29185095]
- Best Pract Res Clin Obstet Gynaecol. 2017 May;41:31-48. [PMID: 28254144]
- Nat Commun. 2013; 4:2578. [PMID: 24153426]
- J Mol Diagn. 2010 Sep; 12(5): 607–610. [PMID: 20639189]
- Mol Cell. 2006 Jun 23; 22(6):719-29. [PMID: 16793542]
- Blood. 2006 Jun 1; 107(11):4223-33. [PMID: 16493006]
- Nat Genet. 2002 May; 31(1):55-9. [PMID: 11967536]
- Oncogene. 2006 Sep 25; 25(43):5898-905. [PMID: 16998504]
- Science. 2002 Jul 26; 297(5581):606-9. [PMID: 12065746]
- J Natl Cancer Inst. 1999 Aug 4; 91(15):1310-6. [PMID: 10433620]